Healon
FDA Approves Dotarem, a New MRI Agent »
"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Healon
Healon (sodium hyaluronate) ®
Sodium Hyaluronate
DRUG DESCRIPTION
Healon (sodium hyaluronate) is a sterile, nonpyrogenic, viscoelastic preparation of a highly purified, noninflammatory, high molecular weight fraction of sodium hyaluronate.
Healon contains 10 mg/mL of sodium hyaluronate dissolved in physiological sodium chloride phosphate bufferlpH 7.0-7.51. This high molecularweight polymeris made up of repeating disaccharide units of N-acetyl-glucosamine and sodium glucuronate linked by b 1-3 and b 1-4 glycosidic bonds.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Healon Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
